Login | Register

Ovarian Cancer – Using Genetics To Predict Chemotherapy Response

According to the April 13 issue of the Journal of the National Cancer Institute, whether or not first-line platinum based chemotherapy can benefit advanced-stage ovarian cancer patients can now potentially be established by using a DNA repair pathway-focused score. Most ovarian cancers are diagnosed when the disease is already in an advanced stage, i.e. stage III and IV...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *